Reduced Viral Replication in Infected HeLa Cells
Cell-based study · HeLa cells infected with VSV-GFP [1]
In HeLa cells infected with VSV-GFP, the tested compounds at 10 μM significantly reduced viral replication compared with DMSO as a control. The readout was GFP fluorescence images.
| Endpoint | Reported result | Reference |
|---|---|---|
| GFP fluorescence images | Reported result 10 μM: all three compounds significantly reduced viral replication | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 μM
- Vehicle
- DMSO
- Co-treatment
- Other interventions in this design: VSV-GFP MOI = 0.1. Compound effect isolated by the comparison: DMSO as a control.
- Reported limits
- Not stated in the sentences used: route, schedule.
Methods and source locations
Compound reported in the paper: NVP-BVU972
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Experimental validation of DeepAVC predictions identifies MNS as a potent broad-spectrum antiviral compound (S244, S254); Methods > Cell culture and viral infection (S397)
GFP fluorescence images: GFP fluorescence images; comparator: DMSO as a control — Results > Experimental validation of DeepAVC predictions identifies MNS as a potent broad-spectrum antiviral compound (S244, S254)